Cargando…
Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?
BACKGROUND: Balloon angioplasty revolutionised percutaneous treatment for coronary ar-tery disease four decades ago, but vessel-threatening dissections, elastic recoil and restenosis were major drawbacks to an otherwise successful long-lasting intervention. Subsequent advances with bare metal stents...
Autores principales: | Merinopoulos, Ioannis, Gunawardena, Tharusha, Wickramarachchi, Upul, Ryding, Alisdair, Eccleshall, Simon, Vassiliou, Vassilios S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872262/ https://www.ncbi.nlm.nih.gov/pubmed/29278215 http://dx.doi.org/10.2174/1573403X14666171226144120 |
Ejemplares similares
-
Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance
por: Gunawardena, Tharusha, et al.
Publicado: (2021) -
Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study
por: Merinopoulos, Ioannis, et al.
Publicado: (2020) -
Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis
por: Corballis, Natasha H., et al.
Publicado: (2021) -
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice
por: Merinopoulos, Ioannis, et al.
Publicado: (2022) -
Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study
por: Gunawardena, Tharusha D., et al.
Publicado: (2023)